Article
AXIN2 germline testing in a French cohort validates pathogenic variants as a rare cause of predisposition to colorectal polyposis and cancer.
Genes, chromosomes & cancer - 1 Apr 2023
Leclerc Julie, Beaumont Marie, Vibert Roseline, Pinson Stéphane, Vermaut Catherine, Flament Cathy, Lovecchio Tonio, Delattre Lucie, Demay Christophe, Coulet Florence, Guillerm Erell, Hamzaoui Nadim, Benusiglio Patrick R, Brahimi Afane, Cornelis François, Delhomelle Hélène, Fert-Ferrer Sandra, Fournier Benjamin P J, Hovnanian Alain, Legrand Clémentine, Lortholary Alain, Malka David, Petit Florence, Saurin Jean-Christophe, Lejeune Sophie, Colas Chrystelle, Buisine Marie-Pierre
Abstract excerpt
Only a few patients with germline AXIN2 variants and colorectal adenomatous polyposis or cancer have been described, raising questions about the actual contribution of this gene to colorectal cancer (CRC) susceptibility. To assess the clinical relevance for AXIN2 testing in patients suspected of genetic predisposition to CRC, we collected clinical and molecular data from the French Oncogenetics laboratories...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
